At a glance
ClinicalIndex Comparison RecordN/ACompleted· 362 enrolled
Drug / intervention
BC1device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of the BC1 Bioelectrical Impedance Body Comp Analyzer
In Brief
A clinical study evaluating BC1 for Body Composition. Completed, enrolled 362 participants across 1 site.
Detailed Summary
The purpose of this study was to validate the Stayhealthy BC1 bioelectrical impedance analyzer to assess percent body fat in children and adults. The BC1 was compared to dual-energy x-ray absorptiometry assessment of body fat for adults and to hydrostatic weighing assessment of body fat for children. We hypothesized that the BC1 would provide similar measures of body fat between devices with acceptable limits of agreement.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBody Composition
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2007
Primary CompletionAug 2009
First PostedSep 2010
TodayJul 2026
First PostedSep 27, 2010
Enrollment StartMay 1, 2007
Primary CompletionAug 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.8 years ago
Interventions
BC1device
Body composition measures taken twice at the same visit for BIA, DEXA, and hydrostatic weighing.